Wordt geladen...
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
Dendritic cell-derived exosomes (Dex) are small extracellular vesicles secreted by viable dendritic cells. In the two phase-I trials that we conducted using the first generation of Dex (IFN-γ-free) in end-stage cancer, we reported that Dex exerted natural killer (NK) cell effector functions in patie...
Bewaard in:
Gepubliceerd in: | Oncoimmunology |
---|---|
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Taylor & Francis
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4839329/ https://ncbi.nlm.nih.gov/pubmed/27141373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1071008 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|